Table IV demonstrated that there was no significant correlation between the sensitivity of BRAF V600E in the plasma and clinical parameters, despite there being a marked trend.
← all excerpts
Detection of ctDNA in the plasma of patients with papillary thyroid carcinoma.
1
—
—